A panel discussion during BIO-Europe Spring
Watch the recorded panel discussion
The Covid-19 pandemic is creating unprecedented healthcare challenges with far reaching effects yet to be measured. There is a need for greater collaboration and communication among researchers, healthcare systems, government agencies, NGOs, and the public at large. Behind the scenes, the biopharma industry is rallying to innovate and collaborate to develop diagnostics, vaccines and treatments as quickly as possible.
In collaboration with
VP, Infections Disease & Diagnostics Policy
Biotechnology Innovation Organization (BIO)